Complete Omics
Who we are
Powered by pioneers in proteomics and multi-omics assays
Complete Omics is based on over 20 years of proteomics technology and clinical development led by the scientists specialized in proteomics and multi-omics assays who first envisioned multi-omics pipelines, omcis-based molecular diagnostics, and clinical proteomics. Their discoveries have positively affected millions of lives, and companies that employ their technology have generated millions of dollars in enterprise value.
Founders

Qing Wang,Ph.D.,MBA
Scientist & Entrepreneur

Hui Zhang,Ph.D
Professor of Pathology

Ming Zhang,Ph.D.
Pioneer in NGS
Leadership
Learn more
Learn more
Learn more
Board of Directors
Founder & Director
Dr. Qing
Wang
Co-Founder & Director
Dr. Hui
Zhang
Co-Founder & Director
Dr. Ming
Zhang
Director
Weibin
Hu
Director
Xin
Huang
Team Leaders
Complete Omics’ team members bring a diversity of scientific and commercial experts, and is foundational to our mission of providing better clinical proteomics and multi-omics assays for better clinical applications.
Morgan Fair
Moleclar Diagnostics Scientist II
Stockton University: Galloway, New Jersey- Bachelor of Science in Biology
Lijun Chen, PhD
Senior Scientist for CAP Institute
Johns Hopkins University
Qiufang Zeng, MS
Senior Manager for Proteomics
Weiwei Hu, MS
Manager for Product
News & Events
The Latest
Find out what's happening at Complete Omics and stay up-to-date with proteomics industry news.
Complete Omics closed a new financing round invested by Qiming Venture Partners!
BALTIMORE, MD – November 28, 2023 --- In a significant move for the biotech industry, Complete Omics Inc., has announced the successful closure of its Series A financing round, with a notable investment from Qiming Venture Partners. This strategic partnership marks a pivotal moment for Complete Omics, enabling the company to accelerate its research and development efforts and expand its innovative diagnostics solutions globally.
Complete Omics announced the establishment of a chinese branch
The administration team and shareholders of Complete Omics are pleased to announce the establishment of a new branch in China, named KangPuBoAo (HangZhou) Biotechnology Inc. (“康普博奥(杭州)生物科技有限公司” in Chinese). This expansion positions Complete Omics as one of the select molecular diagnostic service companies with operations extending beyond national borders.